Lumera Places First Three SPR-Based Proteomic Processors In Academic Labs for Beta Testing | GenomeWeb

After spending about a year developing its ProteomicProcessor Biosensor instrument, which uses surface plasmon resonance technology to enable researchers to identify and analyze the kinetics of protein interactions, Lumera has recently placed three of its ProteomicProcessors in academic laboratories for beta testing.

The first instrument was sold to the Medical University of South Carolina in February, where it will be used by Craig Beeson's research group to study proteins in the mitochondria involved in the pathways of cell death.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.